Both tumor cells and cDC1s engage in competitive uptake of glutamine through the SLC38A2 transporter protein, and the lack of SLC38A2 compromises the ability of DCs to promote T cell priming [7]. The gene discussed is SLC38A2; the disease is neoplasm.